AIM
EW icon

Alambic Investment Management’s Edwards Lifesciences EW Stock Holding History

Alambic Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,490
Closed -$241K – 103
2020
Q2 		$241K Sell
3,490
-7,310
-68% -$519K 0.6% 68
2020
Q1 		$679K Buy
+10,800
New +$779K 1.64% 3

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alambic Investment Management's EW Position: Q3 2020 in Review

Alambic Investment Management sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 3,490 shares — an estimated $241K sold.

Alambic Investment Management first reported a position in EW in Q1 2020 and held it in 2 quarters. The position peaked at $679K in Q1 2020. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Alambic Investment Management reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 3,490 Edwards Lifesciences shares in Q3 2020, an estimated $241K.
  • Alambic Investment Management first reported a position in Edwards Lifesciences in Q1 2020 and held it in 2 quarters.
  • Alambic Investment Management's Edwards Lifesciences position peaked at $679K in Q1 2020.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.